Cora is a very energetic new starter for Prime Global, so it was great to pick her brains and get to know more about her career path. Cora has so much experience and knowledge in the industry, we are excited that she is part of our team to drive Onyx forward!read more >>
We sat down with Roma Patel, one of our Senior Account Managers, to find out about how her career has developed.
Roma worked for us previously as an Account Executive, Senior Account Executive, and Account Manager. After a brief spell with another company, we’re glad to welcome her back to the Prime Global team!read more >>
Prime Global has appointed Sue O’Leary to lead their growing Market Access practice and support the business across the Group’s six full service medical communications agencies. She will be joined by Rebecca Massey, Senior Director, Global Market Access & HEOR.read more >>
The award-winning medical communications agency, Prime Global, has announced the relocation of their New York office. On September 9themployees will move from their office on 57thStreet to a larger, ultra-modern WeWork office on 9th Avenue, in the Hudson Yardsarea.read more >>
A leading medical communications group with a global client base is set to continue its rapid expansion with support of a seven-figure funding package from HSBC UK.read more >>
An internal restructure for Prime Global supports future expansion plans for all six agencies around the globe.read more >>
Thank you so much to ISMPP (International Society for Medical Publication Professionals) for organising another brilliant EU event for 2018. Our highlight was our own Prime Person, Neil Venn, presenting our research on, “Do authors fully utilize opportunities to share supplementary information at conferences?” #ismppeu18 #ismpp #science #publications #researchread more >>
Last week our new Prime member, DOJI, joined us at the Oxford careers fair. With our brilliant new Prime Global 2018 DOJO training scheme, DOJI is here to help you learn and develop at a company that puts people first. #watchthisspace #primeDOJO #learn #training #DOJI #science #careerread more >>
We’ve had such a brilliant and brimming day at the @networkpharma event in Oxford! Thank you to all the people who came. #inspire #ignite #career #medcomms #science# #writing #clientservices #training #programme #dojo #dojiread more >>
Another brilliant view from our new London office. The city looks so compelling from the orange glow of the winter sun!
#london #office #20years #science #career #peopleread more >>
It has been one year since our Prime Global brand launch! We are brimming with pride for how far we have come. We look forward to all the years to come in making the art of science communication.read more >>
What a great event organised by Peter Llewellyn in Manchester! The field of medical communications continues to make exciting progress and we’re proud to help bring the worlds of science and creativity together for the past 20 years. Join us today and reach your potential.read more >>
Return of the Mack
Prime Global is delighted to welcome the return of Christine McCann in the newly created role of People Development Director. Christine began her medical communications career at Prime Global in 2001 and now has extensive industry experience. She is re-joining the Prime Global team brimming with energy and knowledge across many therapeutic areas.
Christine commented on her new position: “I strongly believe that a well-trained, highly performing workforce is a company’s most valuable asset. Prime Global are continuing to invest in their current and future employees – they really do put People First. It’s great to be back!’
Christine’s remit will include driving our Learning and Development Programme for all employees across the Group’s five worldwide office locations. Also, in 2018 Prime Global will launch its dedicated Graduate Development Programme for entry-level writers and client services employees, providing new recruits with a thorough grounding in all aspects of the art of science communications.
Graeme Peterson, Prime Global CEO, stated: “The appointment of Christine McCann as People Development Director marks the start of another exciting period in our ongoing global expansion. We are delighted to have Christine joining our team, supporting people development and enhancing performance at all levels.
With an excellent skill set and a passion to succeed, Prime Global is looking forward to Christine enhancing our brilliant people and helping them thrive in 2018 and beyond.read more >>
According to the World Health Organization (WHO), in 2016, worldwide 40% of all people living with human immunodeficiency virus (HIV) did not know that they had it. That’s 14 million people.
The only way to know if you have HIV is to have an HIV test.
During National HIV Testing Day, many organisations raise awareness of the importance of HIV testing. An early diagnosis can prevent further HIV transmission and allow for timely treatment. This article explores the testing methods and the development of the tests.read more >>
According to the World Health Organization, 8.5% of the worldwide adult population had diabetes in 2014. In 2016, 4.5 million people in the United Kingdom were living with diabetes, of which 1 million were undiagnosed. What causes diabetes and what does it mean to have diabetes?read more >>
Did you know we have an office in Macclesfield? You could be celebrating #MedComms Day with us next year… Get in touch to find out more about our brilliant global career opportunities.read more >>
It’s our 20th year of brilliant Medical Communications. Keep a look out for all the exciting ways we’re celebrating throughout the year starting with #MedComms Dayread more >>
Cystic fibrosis (CF) is a rare disease that causes damage to the respiratory, digestive and reproductive systems. Its incidence varies across the globe. In the USA, CF affects one in every 3500 newborns, and in Europe it’s one in every 2000–3000. Does the low number of patients with CF worldwide discourage scientists from finding a cure? Let’s have a look at what’s currently known about CF as well as existing and future therapies.read more >>
Duchenne muscular dystrophy (DMD) is the most common type of muscular dystrophy, which is characterised by muscle weakening and breakdown. It is a devastating disease that we still don’t fully understand, and currently there is no cure. Patients have a very limited number of therapy options. Scientists are working hard to develop new treatment therapies, but they still face many challenges.read more >>
During mental health awareness month, many organisations around the world report on mental health, so that those who suffer from mental illnesses are not forgotten.
According to the World Health Organization, depression is “a common mental disorder, characterized by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness, and poor concentration”.read more >>
Prime Global Does The Great Manchester 10K Run
On Sunday 28th May, 22 of our Manchester colleagues will be representing Prime Global in the Great Manchester 10K Run.
As The Beatles famously sang, “it was 20 years ago today…” Well, not quite, but 1997 did see the establishment of Prime Global, with just one employees. Now we have over 100 people across three continents and we’re still growing. To celebrate our anniversary, we’ve set ourselves another challenge as part of our on-going programme to give something back to charities close to our hearts.read more >>
There is currently no vaccine available that can prevent human immunodeficiency virus (HIV) infection. Why do scientists believe that an effective and safe HIV vaccine can teach the immune system how to fight HIV? I had a closer look at their latest research of HIV vaccines.read more >>
Market access expert Caroline Ayres helps to de-mystify market access and its importance within global medical communications strategy.read more >>
Our brilliant Prime team enjoying their final night in Dubai, celebrating another successful meeting #medcommsread more >>
@KayDickersin keynote about clinical trial reproducibility and outcomes.read more >>